Assenagon Asset Management
RARE icon

Assenagon Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Assenagon Asset Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04M Sell
120,864
-2,136,807
-95% -$53.1M 0.01% 702
2026
Q1 		$47.3M Buy
2,257,671
+2,057,951
+1,030% +$46.3M 0.07% 206
2025
Q4 		$4.59M Sell
199,720
-52,949
-21% -$1.74M 0.01% 659
2025
Q3 		$7.6M Sell
252,669
-911,086
-78% -$27.3M 0.01% 538
2025
Q2 		$42.3M Buy
1,163,755
+947,865
+439% +$34.2M 0.06% 240
2025
Q1 		$7.82M Buy
215,890
+146,617
+212% +$6.1M 0.01% 464
2024
Q4 		$2.91M Sell
69,273
-76,160
-52% -$3.78M ﹤0.01% 839
2024
Q3 		$8.08M Buy
145,433
+3,259
+2% +$166K 0.01% 583
2024
Q2 		$5.84M Hold
142,174
– – 0.01% 583
2024
Q1 		$6.64M Sell
142,174
-367
-0.3% -$17.3K 0.02% 528
2023
Q4 		$6.82M Sell
142,541
-68,380
-32% -$2.65M 0.02% 551
2023
Q3 		$7.52M Sell
210,921
-23,547
-10% -$933K 0.02% 455
2023
Q2 		$10.8M Sell
234,468
-179,759
-43% -$8.34M 0.04% 347
2023
Q1 		$16.6M Buy
414,227
+254,408
+159% +$10.9M 0.06% 277
2022
Q4 		$7.4M Sell
159,819
-29,275
-15% -$1.15M 0.03% 445
2022
Q3 		$7.83M Buy
189,094
+178,744
+1,727% +$9.19M 0.03% 398
2022
Q2 		$617K Buy
+10,350
New +$637K ﹤0.01% 1188
2022
Q1 		– Sell
-10,454
Closed -$879K – 1541
2021
Q4 		$879K Buy
10,454
+1,346
+15% +$110K ﹤0.01% 1073
2021
Q3 		$821K Buy
+9,108
New +$823K ﹤0.01% 959
2021
Q1 		– Sell
-59,891
Closed -$8.29M – 1289
2020
Q4 		$8.29M Buy
+59,891
New +$7.1M 0.04% 277

Other funds holding RARE

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

Assenagon Asset Management's RARE Position: Q2 2026 in Review

Assenagon Asset Management reduced its Ultragenyx Pharmaceutical (RARE) stake by 95% in Q2 2026, selling an estimated $53.1M and leaving 120,864 shares worth $4.04M. The position accounts for 0.01% of the portfolio, ranked #702.

Assenagon Asset Management first reported a position in RARE in Q4 2020 and has held it in 20 quarters since. The position peaked at $47.3M in Q1 2026. 39 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Assenagon Asset Management held 120,864 shares of Ultragenyx Pharmaceutical worth $4.04M as of Q2 2026.
  • Assenagon Asset Management sold 2,136,807 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $53.1M.
  • Ultragenyx Pharmaceutical made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #702 holding.
  • Assenagon Asset Management first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 20 quarters since.
  • Assenagon Asset Management's Ultragenyx Pharmaceutical position peaked at $47.3M in Q1 2026.
  • 39 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.